Home
Scholarly Works
Dalteparin low molecular weight heparin (LMWH) in...
Conference

Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: A phase II randomized study

Authors

Elit L; Lee A; Julian J; Hoskins P; Julian D; Parpia S; Levine M

Volume

27

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2009

Name of conference

45th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

Orlando, FL

Conference start date

May 29, 2009

Conference end date

June 2, 2009

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team